Leap Therapeutics Inc - LPTX STOCK NEWS

IMPACT

SENTIMENT

11/21/2023 07:00 AM

LPTX : Nasdaq

Leap Therapeutics to Participate at Piper Sandler 35th Annual Healthcare Conference

IMPACT

SENTIMENT

11/13/2023 07:00 AM

LPTX : Nasdaq

Leap Therapeutics Reports Third Quarter 2023 Financial Results

IMPACT

SENTIMENT

09/05/2023 07:00 AM

LPTX : Nasdaq

Leap Therapeutics to Participate at Upcoming Investor Conferences

IMPACT

SENTIMENT

08/14/2023 07:00 AM

LPTX : Nasdaq

Leap Therapeutics Reports Second Quarter 2023 Financial Results

IMPACT

SENTIMENT

07/12/2023 07:00 AM

LPTX : Nasdaq

Leap Therapeutics Announces Initiation of Randomized Controlled Part B of the DeFianCe Study of DKN-01 in Colorectal Cancer Patients

IMPACT

SENTIMENT

06/20/2023 12:30 PM

LPTX : Nasdaq

Leap Therapeutics Announces Reverse Stock Split

IMPACT

SENTIMENT

05/25/2023 05:10 PM

LPTX : Nasdaq

Leap Therapeutics to Present Updated Data from Part A of the DisTinGuish Study of DKN-01 Plus Tislelizumab and Chemotherapy in Gastric Cancer Patients at the 2023 ASCO Annual Meeting

IMPACT

SENTIMENT

05/15/2023 07:00 AM

LPTX : Nasdaq

Leap Therapeutics Reports First Quarter 2023 Financial Results

IMPACT

SENTIMENT

04/26/2023 04:05 PM

LPTX : Nasdaq

Leap Therapeutics to Present Updated Data from Part A of the DisTinGuish Study of DKN-01 Plus Tislelizumab and Chemotherapy in Gastric Cancer Patients at the 2023 ASCO Annual Meeting

IMPACT

SENTIMENT

04/12/2023 07:00 AM

LPTX : Nasdaq

Leap Therapeutics Announces Completion of Enrollment in Part A of the DeFianCe Study of DKN-01 for the Treatment of Colorectal Cancer Patients

Leap Therapeutics Inc

Nasdaq:LPTX

LPTX Rankings

#5650 Ranked by Market Cap

N/A Ranked by Dividends

LPTX Stock Data

Industry Pharmaceutical Preparation Manufacturing

Sector Manufacturing

Website Link

Country US

City Cambridge

About LPTX

leap therapeutics (nasdaq: lptx) is a clinical-stage biopharmaceutical company acquiring and developing novel therapeutics at the leading edge of cancer research. for more information about leap therapeutics, visit http://www.leaptx.com or our public filings with the sec that are available via edgar at http://www.sec.gov or via http://www.investors.leaptx.com.